Urology
Volume 72, Issue 6 , Pages 1194-1197 , December 2008

Inverse Association Between Histologic Inflammation in Needle Biopsy Specimens and Prostate Cancer in Men With Serum PSA of 10-50 ng/mL

  • Tomoaki Terakawa

      Affiliations

    • Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
    • ,
  • Hideaki Miyake

      Affiliations

    • Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
    • Corresponding Author InformationReprint requests: Hideaki Miyake, M.D., Ph.D., Division of Urology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017 Japan
    • ,
  • Naoki Kanomata

      Affiliations

    • Department of Pathology, Kawasaki Medical School, Kurashiki, Japan
    • ,
  • Masafumi Kumano

      Affiliations

    • Department of Pathology, Kawasaki Medical School, Kurashiki, Japan
    • ,
  • Atsushi Takenaka

      Affiliations

    • Department of Pathology, Kawasaki Medical School, Kurashiki, Japan
    • ,
  • Masato Fujisawao

      Affiliations

    • Department of Pathology, Kawasaki Medical School, Kurashiki, Japan

Received 3 May 2008 ,Accepted 3 July 2008.

References 

  1. Stephan C, Jung K, Lein M, et al. PSA and other tissue kallikreins for prostate cancer detection. Eur J Cancer. 2007;43:1918–1926
  2. Oesterling JE. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991;145:907–923
  3. Stamey TA, Yang N, Hay AR, et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987;317:909–916
  4. Okada K, Kojima M, Naya Y, et al. Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer. Urology. 2000;55:892–898
  5. Chang SG, Kim CS, Jeon SH, et al. Is chronic inflammatory change in the prostate the major cause of rising serum prostate-specific antigen in patients with clinical suspicion of prostate cancer?. Int J Urol. 2006;13:122–126
  6. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156–1161
  7. Catalona WJ, Southwick PC, Slawin KM, et al. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology. 2000;56:255–260
  8. Brawer MK, Cheli CD, Neaman IE, et al. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol. 2000;163:1476–1480
  9. Garzotto M, Park Y, Mongoue-Tchokote S, et al. Recursive partitioning for risk stratification in men undergoing repeat prostate biopsies. Cancer. 2005;104:1911–1917
  10. Miyake H, Sakai I, Ishimura T, et al. Significance of cancer detection in the anterior lateral horn on systematic prostate biopsy: impact on pathological findings of radical prostatectomy specimens. BJU Int. 2004;93:53–59
  11. Miyake H, Harada K, Inoue TA, et al. Additional sampling of dorsal apex on systematic prostate biopsy: Impact on early detection of prostate cancer. Urology. 2007;69:738–742
  12. De Marzo AM, Marchi VL, Epstein JI, et al. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999;155:1985–1992
  13. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology. 1983;148:839–843
  14. Hernández J, Thompson IM. Prostate-specific antigen: A review of the validation of the most commonly used cancer biomarker. Cancer. 2004;101:894–904
  15. Gosselaar C, Roobol MJ, Schröder FH. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: Aggressive or insignificant?. BJU Int. 2005;95:231–237
  16. Kato T, Suzuki H, Komiya A, et al. Clinical significance of urinary white blood cell count and serum C-reactive protein level for detection of non-palpable prostate cancer. Int J Urol. 2006;13:915–919
  17. Papsidero LD, Kuriyama M, Wang MC, et al. Prostate antigen: A marker for human prostate epithelial cells. J Natl Cancer Inst. 1981;66:37–42
  18. Hasui Y, Marutsuka K, Asada Y, et al. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate. 1994;25:91–96
  19. Karazanashvili G, Managadze L. Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination. Eur Urol. 2001;39:538–543

PII: S0090-4295(08)00898-4

doi: 10.1016/j.urology.2008.07.028

Urology
Volume 72, Issue 6 , Pages 1194-1197 , December 2008

Article Tools

* Image Usage & Resolution